MedPath

Henry Schein

🇺🇸United States
Ownership
-
Employees
25K
Market Cap
-
Website
Introduction

Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. It operates through the Healthcare Distribution and Technology and Value-Added Services segments. The Healthcare Distribution segment includes consumable products, laboratory, small and large equipment repair services, branded and generic pharmaceuticals, vaccines, surgical, diagnostic tests, infection-control products, and vitamins. The Technology and Value-Added Services segment offers financial on a non-recourse basis, network, and hardware services. The company was founded by Henry Schein and Esther Schein in 1932 and is headquartered in Melville, NY.

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

11

FDA:11

Drug Approvals

Mepivacaine Hydrochloride

Approval Date
Feb 21, 2024
FDA

Lidocaine

Approval Date
Feb 8, 2024
FDA

LIDOCAINE

Approval Date
Feb 5, 2024
FDA

CEFAZOLIN

Approval Date
Jul 12, 2023
FDA

STYPTSTIX

Approval Date
Dec 4, 2019
FDA

Benzo-Jel

Approval Date
May 1, 2015
FDA

Benzo-Jel

Approval Date
May 1, 2015
FDA

Benzo-Jel

Approval Date
May 1, 2015
FDA

Benzo-Jel

Approval Date
May 1, 2015
FDA

Benzo-Jel

Approval Date
Apr 30, 2015
FDA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.